Single User License
INR 442764
Site License
INR 885528
Corporate User License
INR 1158549

Service Tax Additional

select a format
Price

Single User License
USD 6495
Site License
USD 12990
Corporate User License
USD 16995

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


MediPoint: Advanced Wound Dressings-Global Analysis Market Forecasts

MediPoint: Advanced Wound Dressings-Global Analysis Market Forecasts


  Request for Sample Report

Executive Summary

MediPoint: Advanced Wound Dressings-Global Analysis and Market Forecasts

Advanced wound dressings are used to treat a variety of acute wounds, such as burns, cuts, lacerations and abrasions, chronic wounds, such as a diabetic foot ulcers, pressure ulcers and leg ulcers, and surgical wounds sustained during various procedures.

Advanced dressings are a steadily growing segment of the wound care industry, with many companies marketing a wide variety of formats. Emerging markets are expected to demonstrate the highest growth among the 10 major markets (10MM) covered in the report, including the US, France, Germany, Italy, Spain, UK, Japan, China, India and Brazil.

The major segments of advanced wound dressings are foams, alginates, hydrocolloids, hydrofibers, collagens, hydrogels, semi-permeable films, superabsorbents and wound contact layers.

The advanced dressings market will be strongly driven by increasing prevalence of chronic wounds worldwide because rates of risk factors, such as diabetes, obesity and cardiovascular disease, continue to rise.

The global advanced dressings market is largely dominated by the key players such as Smith & Nephew, 3M, Molnlycke, ConvaTec and Coloplast. Smaller manufacturers such as Paul Hartmann, Acelity and Urgo also play an important role in the market.

Unmet needs will future innovation in the development of smart dressings and wound diagnostics.

Key Opinion Leaders emphasize the rise of chronic wounds and associated risk factors as an incentive for the development of better wound care. Furthermore, they highlight technological limitations of certain advanced dressing formats and enumerate unmet needs, such as the need for better clinical evidence.

Highlights

Key Questions Answered

What is the current and future advanced wound dressings market outlook in the developed and emerging markets? What trends are affecting the global market?

Which are the key, high growth markets that dressings manufacturers should expand into? Which markets segments are growing the fastest?

What are the unmet needs with advanced dressings currently on the market? How will emerging technologies such as wound diagnostics and smart dressings fulfill these unmet needs?

What clinical factors affect a physician to use one type of dressing over another? What are the physician perception s and market outlooks of advanced dressings?

What are the challenges that have hindered widespread adoption?

How will emerging trends and changing market landscapes affect the future of advanced dressings?

Key Findings

Emerging economies are seeing the highest growth in the global advanced wound dressings market.

Established dressing formats, such as foams, are widely adopted, but hydrofibers, wound contact layers and superabsorbents are the fastest rising segments as key factors including better exudate management and pain mitigation become more important.

The most proactive wound care firms are providing comprehensive portfolios, undertaking key M&A's, fostering innovation, and focusing wisely on emerging markets to stay competitive.

Rising rates of risk factors to acquiring chronic wounds are the primary drivers of the wound care market. Despite respectable adoption of advanced dressings, unmet needs and non-clinical barriers remain a challenge.

Scope

Overview of wound indications, key factors, epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.

Annualized total advanced dressings market revenue by type of dressings and market outlooks by country through 2021.

Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.

Pipeline analysis: Emerging products and technologies, including novel collagen scaffolds and biomaterial platforms.

Analysis of the current and future market competition in the global advanced dressings market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons To Buy

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the global advanced wound dressings market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global advanced dressings market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in the global and country-specific advanced dressings market from 2011-2020.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

1 Table of Contents

1 Table of Contents 5

1.1 List of Tables 13

1.2 List of Figures 18

2 Introduction 21

2.1 Catalyst 21

2.2 Related Reports 21

3 Industry Overview 22

3.1 Overview 22

3.2 Anatomy & Physiology 22

3.3 Indications 23

3.3.1 Acute Wounds 23

3.3.2 Chronic Wounds 24

3.3.3 Surgical Wounds 26

3.4 Clinical Outcomes 27

3.4.1 Normal Wound Healing Process 27

3.4.2 Key Factors to Wound Management 28

3.5 Applications of Technology 30

3.5.1 Traditional Wound Care Products 30

3.5.2 Current Advanced Wound Dressing Modalities 30

3.5.3 Biologics & Tissue-Engineered Products 34

3.5.4 Device and Equipment Therapies 34

3.6 Advantages and Disadvantages of Technology 35

3.7 Market Access 37

3.7.1 Overview 37

3.7.2 Adoption of Technology 37

3.7.3 Brand Loyalty and Relationships with Manufacturers 39

3.7.4 Purchasing Decisions 41

3.7.5 Influence of Clinical Trials 43

3.8 Regulatory Process 43

3.8.1 Overview 43

3.8.2 United States 44

3.8.3 Europe 45

3.8.4 Japan 46

3.8.5 China 46

3.8.6 India 47

3.8.7 Brazil 48

3.9 Reimbursement 49

3.9.1 Overview 49

3.9.2 United States 50

3.9.3 France 53

3.9.4 Germany 54

3.9.5 Italy 55

3.9.6 Spain 56

3.9.7 United Kingdom 56

3.9.8 Japan 57

3.9.9 China 58

3.9.10 India 59

3.9.11 Brazil 59

3.10 Industry Trends 60

3.10.1 Regulatory Issues & Recalls 60

3.10.2 Mergers, Acquisitions, and Key Partnerships 61

3.11 Economic Impact 63

3.11.1 Indirect Costs 63

3.11.2 Direct Costs 65

4 Unmet Needs 67

4.1 Overview 67

4.2 Optimal Antimicrobial Power 68

4.3 Enhancing Biologically Active Dressings 69

4.4 Minimizing Trauma and Pain at Wound Sites 70

4.5 Designing Multimodal Dressings 71

4.6 Advancing Indicators and Improving Diagnostic Power 71

4.7 Expanding Education and Awareness 72

5 Market Opportunity Analysis 75

5.1 Overview 75

5.2 Complementing Negative Pressure Wound Therapy 75

5.3 Engineering Dressings for Compression Therapy 76

5.4 Addressing Radiation Oncology Burns 76

5.5 Progressing Scar Management 77

5.6 Implementing Topical Drug Delivery 78

6 Market Drivers and Barriers 79

6.1 Drivers 79

6.1.1 Occurrence of Burns 79

6.1.2 Rising Rates of Diabetes 80

6.1.3 Aging Population 81

6.1.4 Rising Rates of Vascular Diseases 81

6.1.5 Rising Rates of Obesity 82

6.1.6 Need for Cost Savings 82

6.2 Barriers 83

6.2.1 Diminished Role of Advanced Dressings in Standard Therapies 83

6.2.2 Lack of Reimbursements 84

6.2.3 Complexities in Healthcare Systems 85

6.2.4 Regulatory Challenges 86

6.2.5 Lack of Clinical Data 87

6.2.6 Medical Device Excise Tax 88

6.2.7 Availability of Venture Capital 88

7 Competitive Assessment 89

7.1 Overview 89

7.2 Technology and Product Offerings 89

7.3 Product Profiles 90

7.3.1 Smith & Nephew 90

7.3.2 3M Health Care 95

7.3.3 Molnlycke Health Care 98

7.3.4 ConvaTec 101

7.3.5 Coloplast 104

7.3.6 Paul Hartmann 107

7.3.7 Systagenix Wound Management 110

7.3.8 Medline Industries 114

7.3.9 Laboratoires Urgo 117

7.3.10 BSN Medical 120

7.3.11 Covidien 123

7.3.12 B. Braun 126

7.3.13 Hollister 129

7.3.14 Derma Sciences 133

7.3.15 Lohmann & Rauscher 136

7.3.16 Advanced Medical Solutions 139

7.3.17 Nitto Denko 142

7.3.18 Winner Medical Group 142

7.3.19 DeRoyal Industries 144

7.3.20 Genewel 147

7.4 SWOT For Each Category 149

7.4.1 SWOT, Foams 149

7.4.2 SWOT, Hydrocolloids 149

7.4.3 SWOT, Semi-Permeable Films 150

7.4.4 SWOT, Hydrogels 150

7.4.5 SWOT, Alginates 151

7.4.6 SWOT, Hydrofibers 151

7.4.7 SWOT, Collagens 152

7.4.8 SWOT, Superabsorbents 152

7.4.9 SWOT, Wound Contact Layers 153

8 Pipeline Assessment 154

8.1 Overview 154

8.2 Product Profiles 154

8.2.1 MxBiodevices: Dermagrid 154

8.2.2 PolyNovo: NovoSorb BTM 155

8.2.3 Tissue Therapies: VitroGro ECM 156

8.2.4 Edixomed: ProNOx 157

8.2.5 KeraNetics: KeraStat 158

8.2.6 Arteriocyte: Magellan Bio-Bandage 159

8.2.7 Nanotherapeutics: NanoDOX 160

8.2.8 DeCell Technologies: DermGEN 161

8.2.9 Eqalix: OmegaSkin 162

9 Clinical Trials to Watch 163

9.1 Overview 163

9.2 Clinical Trial Profiles 163

9.2.1 Adocia 163

9.2.2 DermaPACE 163

9.2.3 Amnioexcel and DSC127 164

9.2.4 TransCu O2 165

9.2.5 Woundchek 165

10 Current and Future Players 167

10.1 Overview 167

10.2 Trends in Corporate Strategy 167

10.3 Company Profiles 168

10.3.1 Smith & Nephew 168

10.3.2 3M Health Care 170

10.3.3 Molnlycke Health Care 172

10.3.4 ConvaTec 174

10.3.5 Coloplast 176

10.3.6 Paul Hartmann 178

10.3.7 Systagenix Wound Management 179

10.3.8 Medline Industries 181

10.3.9 Laboratoires Urgo 183

10.3.10 BSN Medical 185

10.3.11 Covidien 186

10.3.12 B. Braun 188

10.3.13 Hollister 190

10.3.14 Derma Sciences 192

10.3.15 Lohmann & Rauscher 194

10.3.16 Advanced Medical Solutions Group 196

10.3.17 Nitto Denko 197

10.3.18 Winner Medical Group 199

10.3.19 Genewel 200

10.3.20 DeRoyal Industries 201

11 Strategic Competitive Assessment 203

11.1 Company Market Share 203

11.1.1 Global Overview 203

11.1.2 Company Share by Region 205

11.1.3 Company Share by Individual Country 207

12 Market Outlooks by Market Segment 217

12.1 Market Segment Share 217

12.1.1 Global 217

12.1.2 By Region 219

13 Market Outlooks by Geography 223

13.1 Global Overview 223

13.2 US 229

13.3 France 232

13.4 Germany 235

13.5 Italy 238

13.6 Spain 241

13.7 UK 244

13.8 Japan 247

13.9 China 250

13.10 India 253

13.11 Brazil 256

14 Appendix 259

14.1 Bibliography 259

14.2 Abbreviations 295

14.3 Report Methodology 298

14.3.1 Overview 298

14.3.2 Coverage 298

14.3.3 Secondary Research 299

14.4 Forecasting Methodology 300

14.5 Physicians and Specialists Included in This Study 301

14.5.1 Key Opinion Leaders 301

14.5.2 Primary Research Summary 302

14.6 About the Authors 303

14.6.2 Global Head of Healthcare 304

14.7 About GlobalData 305

14.8 Disclaimer 305

1.2 List of Figures

Figure 1: Usage Frequency of Antimicrobials 38

Figure 2: Influences on Product Adoption 39

Figure 3: Frequency of Advanced Dressing Usage Based on Brand 40

Figure 4: Influencers of Purchasing Decisions 42

Figure 5: Reimbursement Perceptions 49

Figure 6: Unmet Needs 67

Figure 7: Global Company Market Shares for Advanced Wound Dressings, 2013 203

Figure 8: 5EU Company Market Shares for Advanced Wound Dressings, 2013 205

Figure 9: APAC Company Market Shares for Advanced Wound Dressings, 2013 206

Figure 10: US Company Market Shares for Advanced Wound Dressings, 2013 207

Figure 11: France Company Market Shares for Advanced Wound Dressings, 2013 208

Figure 12: Germany Company Market Shares for Advanced Wound Dressings, 2013 209

Figure 13: Italy Company Market Shares for Advanced Wound Dressings, 2013 210

Figure 14: Spain Company Market Shares for Advanced Wound Dressings, 2013 211

Figure 15: United Kingdom Company Market Shares for Advanced Wound Dressings, 2013 212

Figure 16: Japan Company Market Shares for Advanced Wound Dressings, 2013 213

Figure 17: China Company Market Shares for Advanced Wound Dressings, 2013 214

Figure 18: India Company Market Shares for Advanced Wound Dressings, 2013 215

Figure 19: Brazil Company Market Shares for Advanced Wound Dressings, 2013 216

Figure 20: Global Market Value Forecast by Market Segment for Advanced Wound Dressings, 2011-2021 217

Figure 21: 5EU Market Value Forecast by Market Segment for Advanced Wound Dressings, 2011-2021 219

Figure 22: APAC Market Value Forecast by Market Segment for Advanced Wound Dressings, 2011-2021 221

Figure 23: Global Sales Volume for Advanced Wound Dressings, Number of Units, 2011-2021 223

Figure 24: Global Market Value Forecast by Country, USD m, 2011-2021 225

Figure 25: Global Market Share Comparison by Country, 2014 & 2021 226

Figure 26: 5EU Market Share Comparison by Country, 2014 & 2021 227

Figure 27: APAC Market Share Comparison by Country, 2014 & 2021 228

Figure 28: US Market Value Forecast by Market Segment, USD m, 2011-2021 229

Figure 29: US Market Value Comparison by Market Segment, 2014 & 2021 231

Figure 30: France Market Value Forecast by Market Segment, USD m, 2011-2021 232

Figure 31: France Market Value Comparison by Market Segment, 2014 & 2021 234

Figure 32: Germany Market Value Forecast by Market Segment, USD m, 2011-2021 235

Figure 33: Germany Market Value Comparison by Market Segment, 2014 & 2021 237

Figure 34: Italy Market Value Forecast by Market Segment, USD m, 2011-2021 238

Figure 35: Italy Market Value Comparison by Market Segment, 2014 & 2021 240

Figure 36: Spain Market Value Forecast by Market Segment, USD m, 2011-2021 241

Figure 37: Spain Market Value Comparison by Market Segment, 2014 & 2021 243

Figure 38: UK Market Value Forecast by Market Segment, USD m, 2011-2021 244

Figure 39: UK Market Value Comparison by Market Segment, 2014 & 2021 246

Figure 40: Japan Market Value Forecast by Market Segment, USD m, 2011-2021 247

Figure 41: Japan Market Value Comparison by Market Segment, 2014 & 2021 249

Figure 42: China Market Value Forecast by Market Segment, USD m, 2011-2021 250

Figure 43: China Market Value Comparison by Market Segment, 2014 & 2021 252

Figure 44: India Market Value Forecast by Market Segment, USD m, 2011-2021 253

Figure 45: India Market Value Comparison by Market Segment, 2014 & 2021 255

Figure 46: Brazil Market Value Forecast by Market Segment, USD m, 2011-2021 256

Figure 47: Brazil Market Value Comparison by Market Segment, 2014 & 2021 258

Figure 48: Primary Research Participants By Country 302

1.1 List of Tables

Table 1: Types of Burns: Characteristics and Treatment Options 23

Table 2: Stages of Pressure Ulcers 26

Table 3: Types of Surgical Wounds 27

Table 4: Sample HCPCS Codes for Advanced Wound Dressings 51

Table 5: ICD-9 Coding Guide for Chronic and Acute Wounds 52

Table 6: Reimbursement Classification for Medical Devices in Japan 58

Table 7: Smith & Nephew Advanced Wound Dressings Marketed Products 91

Table 8: Smith & Nephew Advanced Wound Dressings Product Portfolio SWOT Analysis, 2015 95

Table 9: 3M Advanced Wound Dressings Marketed Products 96

Table 10: 3M Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 98

Table 11: Molnlycke Advanced Wound Dressings Marketed Products 99

Table 12: Molnlycke Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 101

Table 13: ConvaTec Advanced Wound Dressings Marketed Products 102

Table 14: ConvaTec Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 104

Table 15: Coloplast Advanced Wound Dressings Marketed Products 105

Table 16: Coloplast Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 107

Table 17: Paul Hartmann Advanced Wound Dressings Marketed Products 108

Table 18: Paul Hartmann Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 109

Table 19: Systagenix Advanced Wound Dressings Marketed Products 111

Table 20: Systagenix Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 114

Table 21: Medline Industries Advanced Wound Dressings Marketed Products 115

Table 22: Medline Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 117

Table 23: Laboratoires Urgo Advanced Wound Dressings Marketed Products 118

Table 24: Urgo Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 120

Table 25: BSN Medical Advanced Wound Dressings Marketed Products 121

Table 26: BSN Medical Advanced Wound Dressings Product Portfolio SWOT Analysis, 2015 123

Table 27: Covidien Advanced Wound Dressings Marketed Products 124

Table 28: Covidien Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 126

Table 29: B. Braun Advanced Wound Dressings Marketed Products 127

Table 30: B. Braun Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 129

Table 31: Hollister Advanced Wound Dressings Marketed Products 130

Table 32: Hollister Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 132

Table 33: Derma Sciences Advanced Wound Dressings Marketed Products 134

Table 34: Derma Sciences Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 136

Table 35: Lohmann & Rauscher Advanced Wound Dressings Marketed Products 137

Table 36: Lohmann & Rauscher Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015 139

Table 37: Advanced Medical Solutions Advanced Wound Dressings Marketed Products 140

Table 38: Advanced Medical Solutions Advanced Wound Dressings Product Portfolio SWOT Analysis, 2015 141

Table 39: Nitto Denko Advanced Wound Dressings Marketed Products 142

Table 40: Winner Medical Group Advanced Wound Dressings Marketed Products 143

Table 41: DeRoyal Industries Advanced Wound Dressings Marketed Products 145

Table 42: DeRoyal Industries Advanced Wound Dressings Product Portfolio SWOT Analysis, 2015 147

Table 43: Genewel Advanced Wound Dressings Marketed Products 148

Table 44: Foams SWOT Analysis, 2015 149

Table 45: Hydrocolloids SWOT Analysis, 2015 149

Table 46: Semi-Permeable Films SWOT Analysis, 2015 150

Table 47: Hydrogels SWOT Analysis, 2015 150

Table 48: Alginates SWOT Analysis, 2015 151

Table 49: Hydrofibers SWOT Analysis, 2015 151

Table 50: Collagens SWOT Analysis, 2015 152

Table 51: Superabsorbents SWOT Analysis, 2015 152

Table 52: Wound Contact Layers SWOT Analysis, 2015 153

Table 53: Dermagrid SWOT Analysis, 2015 155

Table 54: NovoSorb BTM SWOT Analysis, 2015 156

Table 55: VitroGro SWOT Analysis, 2015 157

Table 56: ProNOx SWOT Analysis, 2015 158

Table 57: KeraStat SWOT Analysis, 2015 159

Table 58: Magellan Bio-Bandage SWOT Analysis, 2015 160

Table 59: nanoDOX SWOT Analysis, 2015 161

Table 60: DermGEN SWOT Analysis, 2015 162

Table 61: OmegaSkin SWOT Analysis, 2015 162

Table 62: Smith & Nephew Company Profile 169

Table 63: Smith & Nephew SWOT Analysis, 2015 170

Table 64: 3M Company Profile 171

Table 65: 3M SWOT Analysis, 2015 172

Table 66: Molnlycke Company Profile 173

Table 67: Molnlycke SWOT Analysis, 2015 174

Table 68: ConvaTec Company Profile 175

Table 69: ConvaTec SWOT Analysis, 2015 176

Table 70: Coloplast Company Profile 176

Table 71: Coloplast SWOT Analysis, 2015 177

Table 72: Paul Hartmann Company Profile 178

Table 73: Paul Hartmann SWOT Analysis, 2015 179

Table 74: Systagenix Company Profile 180

Table 75: Systagenix SWOT Analysis, 2015 181

Table 76: Medline Company Profile 182

Table 77: Medline SWOT Analysis, 2015 183

Table 78: Laboratoires Urgo Company Profile 184

Table 79: Laboratoires Urgo SWOT Analysis, 2015 184

Table 80: BSN Medical Company Profile 185

Table 81: BSN Medical SWOT Analysis, 2015 186

Table 82: Covidien Company Profile 187

Table 83: Covidien SWOT Analysis, 2015 188

Table 84: B. Braun Company Profile 189

Table 85: B. Braun SWOT Analysis, 2015 190

Table 86: Hollister Company Profile 191

Table 87: Hollister SWOT Analysis, 2015 192

Table 88: Derma Sciences Company Profile 193

Table 89: Derma Sciences SWOT Analysis, 2015 194

Table 90: Lohmann & Rauscher Company Profile 194

Table 91: Lohmann & Rauscher SWOT Analysis, 2015 195

Table 92: Advanced Medical Solutions Company Profile 196

Table 93: Advanced Medical Solutions SWOT Analysis, 2015 197

Table 94: Nitto Denko Company Profile 198

Table 95: Nitto Denko SWOT Analysis, 2015 199

Table 96: Winner Medical Group Company Profile 199

Table 97: Winner Medical Group SWOT Analysis, 2015 200

Table 98: Genewel SWOT Analysis, 2015 201

Table 99: DeRoyal Industries Company Profile 201

Table 100: DeRoyal SWOT Analysis, 2015 202

Table 101: Global Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 218

Table 102: 5EU Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 220

Table 103: APAC Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 222

Table 104: Total Sales Volume by Country for Advanced Wound Dressings, in number of units sold, 2011-2021 224

Table 105: Global Market Value Forecast by Country for Advanced Wound Dressings, USD m, 2011-2021 225

Table 106: US Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 230

Table 107: France Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 233

Table 108: Germany Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 236

Table 109: Italy Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 239

Table 110: Spain Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 242

Table 111: UK Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 245

Table 112: Japan Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 248

Table 113: China Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 251

Table 114: India Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 254

Table 115: Brazil Market Value Forecast by Market Segment for Advanced Wound Dressings, USD m, 2011-2021 257

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Smith & Nephew

3M Health Care

Molnlycke Health Care

ConvaTec

Coloplast

Paul Hartmann

Systagenix Wound Management

Medline Industries

Laboratoires Urgo

BSN Medical

Covidien

B. Braun

Hollister

Derma Sciences

Lohmann & Rauscher

Advanced Medical Solutions Group

Nitto Denko

Winner Medical Group

Genewel

DeRoyal Industries


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com